Mumps Antibody, IgM, Serum
Test Codes
EPIC: LAB3075 Beaker: XMUMP, MAYO: MMPM
Department
Send Outs
Instructions
Acute and convalescent specimens must be labeled as such; parallel testing is preferred, and convalescent specimens must be received within 30 days from receipt of the acute samples. Please mark sample plainly as "acute" or "convalescent."
Specimen Collection Criteria
Collect (preferred specimen): One Gold-top SST tube.
Also acceptable: One plain Red-top tube.
Physician Office/Draw Specimen Preparation
Let specimen clot 30-60 minutes then centrifuge to separate serum from cells within two hours of collection. Transfer serum to a plastic transport tube and refrigerate (2-8°C or 36-46°F).
Preparation for Courier Transport
Transport: 1.0 mL serum, refrigerated (2-8°C or 36-46°F). (Minimum: 0.5 mL)
Rejection Criteria
- Hemolyzed specimens.
- Severely lipemic specimens.
- Specimens not collected and processed as indicated.
In-Lab Processing
Let specimen clot 30-60 minutes then centrifuge to separate serum from cells within two hours of collection. Transfer serum to a plastic transport tube and refrigerate (2-8°C or 36-46°F).
Transport: 1.0 mL serum, refrigerated (2-8°C or 36-46°F). (Minimum: 0.5 mL)
Storage
Specimen Stability for Testing:
Room Temperature (20-26°C or 68-78.8°F): unacceptable
Refrigerated (2-8°C or 36-46°F): 14 days
Frozen (-20°C/-4°F or below): 14 days
Specimen Storage in Department Prior to Disposal:
Specimen retention time is determined by the policy of the reference laboratory. Contact the Send Outs Laboratory with any questions.
Laboratory
Sent to Mayo Clinic Laboratories in Rochester, MN.
Performed
Tuesday.
Results available in 1-4 days.
Reference Range
By report.
Test Methodology
Enzyme-Linked Immunosorbent Assay.
Interpretation
Appearance of an IgM antibody response normally occurs 7-14 days after the onset of disease. Testing immediately post-exposure is of no value without a later convalescent specimen. While the presence of IgM antibodies suggests current or recent infection, low levels of IgM antibodies may occasionally persist for more than 12 months post-infection or immunization. Such a residual IgM response may be distinguished from early IgM response to infection by testing sera from patients 2-3 weeks later for changing levels of specific IgM antibodies.
Clinical Utility
The clinical diagnosis of an acute infection may be supported by the demonstration of virus-specific IgM. Assays for IgM are more useful than IgG assays, since cross-reactions have not been observed. Positive IgM mumps antibody suggests infection within the past 2-3 months. For paired sample results, an acute result less than 1:10 and convalescent greater than 1:10, or a four-fold rise in titer, suggests a primary infection with mumps virus unless the individual has recently acquired passive antibody.
Clinical Disease
Once transmitted, the mumps virus can produce symptomatic and asymptomatic infections. Typical mumps is an acute, self-limiting disease characterized by bilateral or unilateral parotitis. However, mumps virus infections can sometimes cause meningoencephalitis, orchitis, ovaritis, pancreatitis, thyroiditis, or infections of the eye or inner ear. (1)
Epidemiology
Mumps is endemic throughout the world. Prior to licensing of the live attenuated mumps vaccine, epidemics occurred every 2-5 years with the peak incidence occurring from January through May. In the pre-vaccine era, more than 50% of cases occurred in the 5-to 9-year group and 90% of disease occurred in children under 14 years of age. Today, more than 50% of mumps cases occur in teenagers and young adults. (1)
Incubation Period
The incubation period is 16-18 days with a range of 2-4 weeks. Patients are infectious from 9 days prior, to 8 days after, the development of parotitis. Urine from mumps patients should be considered infectious for two weeks after onset of symptoms. (1)
Transmission
Mumps is transmitted by direct contact and through inhalation of infectious aerosols. In addition, the virus can be spread indirectly by autoinoculation of the nose or mouth after handling infected fomites, soiled handkerchiefs, or tissues. (1)
Reference
- Wiedbrauk D, Johnston SLG. Manual of Clinical Virology, Raven Press, New York, NY, 1993.
CPT Codes
86735
Contacts
Send Outs Laboratory – RO
248-551-9045
Name: Send Outs Laboratory – RO
Location:
Phone: 248-551-9045
Last Updated
11/6/2024
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.